Wim Meijberg

Wim Meijberg  is working as Business Developer at the IXA office Amsterdam UMC-locatie AMC

Wim Meijberg got his PhD in Biophysical Chemistry from the University of Groningen. After 2 years as a Marie Curie postdoctoral fellow at Imperial College in London he returned to Groningen to become project leader and later CSO at Biomade Technology, an organization working at the intersection of science and business in the field of molecular nanotechnology. In 2010 he joined Crucell (later Janssen Vaccines and Prevention) as senior scientist and project leader, focusing on novel vaccines for Infectious Diseases. Among his responsibilities was the initiation and management of research collaborations with external organisations, both industrial and academic. He joined the IXA office at the AMC  in 2017.

Areas of expertise: life sciences, (bio)chemistry, drug delivery, infectious diseases and vaccines, collaborative research contracts, intellectual property.

Contact details: +31 (0)20 566 1356